rxstat › Shortages › Betahistine
Betahistine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Betahistine products are in shortage in Canada (4 of 21 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 1, 2027.
In shortage since
Nov 5, 2024
Est. full return
Jan 1, 2027
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortagePMS-BETAHISTINE
24MG · TABLET · PHARMASCIENCE INC
DIN 02330237 · since ?, est. end Jan 1, 2027 · Disruption of the manufacture of the drug.
Active shortagePMS-BETAHISTINE
16MG · TABLET · PHARMASCIENCE INC
DIN 02330210 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortageBETAHISTINE
24MG · TABLET · SANIS HEALTH INC
DIN 02466457 · since Dec 3, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortageBETAHISTINE
16MG · TABLET · SANIS HEALTH INC
DIN 02466449 · since Nov 5, 2024, no end estimate · Disruption of the manufacture of the drug.
DiscontinuedTEVA-BETAHISTINE
24MG · TABLET · TEVA CANADA LIMITED
DIN 02280205
DiscontinuedTEVA-BETAHISTINE
16MG · TABLET · TEVA CANADA LIMITED
DIN 02280191
DiscontinuedTEVA-BETAHISTINE
8MG · TABLET · TEVA CANADA LIMITED
DIN 02280183
ResolvedTEVA-BETAHISTINE
8MG · TABLET · TEVA CANADA LIMITED
DIN 02280183 · ended Aug 28, 2025 · Disruption of the manufacture of the drug.
ResolvedTEVA-BETAHISTINE
24MG · TABLET · TEVA CANADA LIMITED
DIN 02280205 · ended Aug 28, 2025 · Disruption of the manufacture of the drug.
ResolvedTEVA-BETAHISTINE
16MG · TABLET · TEVA CANADA LIMITED
DIN 02280191 · ended Aug 28, 2025 · Disruption of the manufacture of the drug.
AvoidedSERC
16MG · TABLET · BGP PHARMA ULC
DIN 02243878 · ended Jun 16, 2025 · Demand increase for the drug.
ResolvedMINT-BETAHISTINE
8MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02538121 · ended Jun 13, 2025 · Requirements related to complying with good manufacturing practices.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Betahistine is currently affected by 4 active shortage reports filed with Health Canada by PHARMASCIENCE INC, SANIS HEALTH INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Betahistine is classified under “ANTIVERTIGO PREPARATIONS” (ATC N07CA).
Recent changes
Common questions
When will Betahistine be back in stock in Canada?
The latest manufacturer estimate is Jan 1, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Betahistine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All antivertigo preparations shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.